Case Report
Copyright ©2013 Baishideng Publishing Group Co.
World J Gastroenterol. Aug 21, 2013; 19(31): 5187-5194
Published online Aug 21, 2013. doi: 10.3748/wjg.v19.i31.5187
Table 1 Review of the English and Japanese literature for cases of recurrent or unresectable primary gastric choriocarcinoma treated with chemotherapy after 1990
CasesAuthorsAge (yr)/sexTypeSite of metastasisChemotherapy regimenResponsePrognosis (mo)
1Present case65/FRecurrentLiverEMA/COCR115 NED
2Waseda et al[5]68/MUnresectableLiverEPCR24 NED
3Shastri et al[8]44/MUnresectableLiverBEPSize reduction12 DOD
4Shimuzu et al[9]43/FUnresectableDistant lymph nodesTS-1/CDDPSize reduction7 DOD
5Yoon et al[10]62/MUnresectableLiver5-FU/USAN/L-OHPProgression16 DOD
PTX/CDDPProgression
5-FU/USAN/CPT-11Progression
BEPProgression
EMA/COProgression
VIPProgression
6Yoon et al[10]45/MUnresectableLiverBEPProgression12 DOD
VIPProgression
EMA/COProgression
5-FU/USAN/CPT-11Progression
7Kanemura et al[11]79/MRecurrentNo dataTS-1/PTXProgression5 DOD
8Yasumoto et al[12]76/FUnresectableLiver5-FUProgression1 DOD
9Mori et al[13]36/FRecurrentBrain and lungEMA/COCR54 NED
10Enokido et al[14]54/MUnresectableLiverTS-1Progression3 DOD
11Adachi et al[15]78/MUnresectableLiverTS-1CR12 NED
12Kishimoto et al[16]69/MRecurrentLiverEpi-ADM/MMC (TACE)Progression17 DOD
5-FU (HAI)Progression
UFTProgression
13Kawaguchi et al[17]60 MRecurrentLiverMTX/BLM/CDDP/CPAProgression5 DOD
14Liu et al[18]36/FUnresectableColon (infiltration)BEPSize reduction6 DOD
VBL/IFM/CDDPProgression
15Inaki et al[19]56/MRecurrentLiverMAC (second-line after UFT as adjuvant)Progression3 DOD
16Bayhan et al[20]26/FRecurrentLungMACSize reduction18 NED
17Satoh et al[21]58/MRecurrentParaaortic lymph nodesVP-16/CDDPProgression6 DOD
18Kinoshita et al[22]74/MUnresectableLiverMTXProgression3 AWD
19Imai et al[23]63/FRecurrentLiverMAProgression3 DOD
20Fujimoto et al[24]57/MRecurrentLiverMACProgression6 DOD
21Ogura et al[25]45/FRecurrentLiver5-FU/MMC/Epi-ADM (HAI)Size reduction10 DOD
VP-16/CDDPProgression
22Kan et al[26]67/MUnresectableLiver5'DFUR/CDDPSize reduction10 DOD
5'DFUR/CDDP/VP-16Progression
MTXProgression
23Saito et al[27]57/MRecurrentCEA elevation5-FU/CDDP (second-line after Tegafur as adjuvant)SD12 AWD
24Imatake et al[28]50/MUnresectableLiverMMC/5-FU/lentinanProgression2 DOD
25Okada et al[29]57/FRecurrenthCG elevationVACProgression7 DOD
26Kobayashi et al[30]60/MUnresectableLiverMTX/ADM (HAI)Progression5 DOD
27Masuda et al[31]79/MUnresectableLiverUFTProgression1.5 DOD